CohBar的股东预计将持有约15%的CohBar普通股,合并前的Morphogenesis股东预计将持有约77%的CohBar普通股。
CohBar还与Morphogenesis现有投资者的关联公司签署了一...查看全文
蹊之美股生物医药2021-08-12 21:30
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
CohBar (NASDAQ:CWBR)+25%Allied Healthcare Products (NASDAQ:AHPI)+18%Doximity (NYSE:DOCS)+33%Orphazyme (NASDAQ:ORPH) +16%Fulcrum Therapeutics (NASDAQ:FULC) +7%
Losers:
Biodesix...查看全文
蹊之美股生物医药2021-08-12 03:30
作者:王医生
微信公众号:蹊之美股生物医药 / CaesarBiotech
标的公司:CohBar, Inc. (NASDAQ:CWBR)
CohBar, Inc. (CWBR) 是一家临床阶段的生物技术公司,开发基于线粒体的疗法来治疗慢性疾病和延长健康寿命,该公司今天宣布了多中心、随机、双盲、安慰剂对照的 1a/1b 期临床试...查看全文
$CohBar(CWBR)$ 8-K Current report, item 3.01 Accession Number: 0001213900-23-090274 Act: 34 Size: 208 KB 网页链接
$CohBar(CWBR)$ 8-K Current report, items 5.02 and 8.01 Accession Number: 0001213900-23-085601 Act: 34 Size: 221 KB 网页链接
$CohBar(CWBR)$ 8-K Current report, item 1.02 Accession Number: 0001213900-23-081954 Act: 34 Size: 213 KB 网页链接
$CohBar(CWBR)$ 425 Prospectuses and communications, business combinations Accession Number: 0001013762-23-006466 Act: 34 Size: 38 KB 网页链接
$CohBar(CWBR)$ 8-K Current report, items 5.07 and 8.01 Accession Number: 0001013762-23-006465 Act: 34 Size: 217 KB 网页链接
$CohBar(CWBR)$ 8-K/A [Amend] Current report, item 5.07 Accession Number: 0001013762-23-002537 Act: 34 Size: 206 KB 网页链接
$CohBar(CWBR)$ 425 Prospectuses and communications, business combinations Accession Number: 0001013762-23-002539 Act: 34 Size: 28 KB 网页链接
$CohBar(CWBR)$ 8-K Current report, items 5.07 and 8.01 Accession Number: 0001013762-23-001396 Act: 34 Size: 224 KB 网页链接
$CohBar(CWBR)$ 425 Prospectuses and communications, business combinations Accession Number: 0001013762-23-001398 Act: 34 Size: 43 KB 网页链接
$CohBar(CWBR)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-002636 Act: 33 Size: 1 KB 网页链接